Xeris Biopharma Holdings (XERS) Cash & Current Investments (2020 - 2026)
Xeris Biopharma Holdings (XERS) reported Cash & Current Investments of $121.75 million for Q2 2026, up 105.4% from $59.29 million a year earlier and up 8.9% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Xeris Biopharma Holdings posted Cash & Current Investments of $111.04 million, up 55.0% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $71.62 million in FY2024 (-1.1%), $72.45 million in FY2023 (-40.6%), $121.97 million in FY2022 (+19.1%) and $102.43 million in FY2021 (-23.4%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Current Investments since Q4 2022.
- Year over year, Cash & Current Investments has now increased in each of the last four quarters, with growth averaging 28.9% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was Q3 2021 (growth of 145.4%); the low point was Q4 2023 (a decline of 40.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $111.75 million (Q1 2026), $111.04 million (Q4 2025) and $91.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 8.17 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Xeris Biopharma Holdings | 2.89 Bn | 2.41 Bn | 94.80 Mn | 131.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 131.08 Mn |
| Jun 30, 2026 | 121.75 Mn |
| Mar 31, 2026 | 111.75 Mn |
| Dec 31, 2025 | 111.04 Mn |
| Sep 30, 2025 | 91.60 Mn |
| Jun 30, 2025 | 59.29 Mn |
| Mar 31, 2025 | 58.44 Mn |
| Dec 31, 2024 | 71.62 Mn |
| Sep 30, 2024 | 69.40 Mn |
| Jun 30, 2024 | 77.57 Mn |
| Mar 31, 2024 | 87.35 Mn |
| Dec 31, 2023 | 72.45 Mn |
| Sep 30, 2023 | 65.98 Mn |
| Jun 30, 2023 | 80.67 Mn |
| Mar 31, 2023 | 95.10 Mn |
| Dec 31, 2022 | 121.97 Mn |
| Sep 30, 2022 | 93.43 Mn |
| Jun 30, 2022 | 111.55 Mn |
| Mar 31, 2022 | 132.15 Mn |
| Dec 31, 2021 | 102.43 Mn |
API Access
Xeris Biopharma Holdings Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();